Allscripts Leadership & Board of Directors
With a deep history in healthcare, Allscripts leadership is dedicated to expanding Allscripts to ensure every aspect of healthcare delivery is brought to the next level.
Rick is the Chief Executive Officer of Allscripts. As CEO, Rick leads the company’s vision to deliver its obligation to build Open, Connected Communities of Health. For Everyone. Previously, Rick was managing day-to-day operations of all business units as President. He initially joined Allscripts in 2012 as chief financial officer to oversee the company’s financial operations, business development and strategy.
Rick served as the chief financial officer and treasurer for AAR Corp. after joining the company in 2006 as vice president of acquisitions and strategic investment. He spent more than ten years at UAL Corporation in progressively more senior financial and business development roles, including senior vice president of business development as well as president and CFO of the company's loyalty services subsidiary. He also served as vice president of finance for online retailer Ourhouse.com. Rick began his career in the audit practice of Arthur Andersen & Co., LLP, where he held multiple increasingly responsible positions.
Rick has served on the board of the Juvenile Diabetes Research Foundation. He holds a Bachelor of Science degree in accounting, with honors, from Marquette University and a Master of Business Administration, with concentrations in strategy and finance, from Northwestern University’s Kellogg Graduate School of Management.
Rich Elmore is responsible for corporate development and strategy at Allscripts. In that capacity, he has driven new initiatives through acquisitions and innovations related to delivery system reform, hospital solutions, health analytics, care coordination, population health, health information exchange, post-acute care, health plan solutions and patient/consumer engagement. During a one-year leave of absence from Allscripts, he served as Standards Coordinator for the Department of Health and Human Services, Office of the National Coordinator for Health Information Technology (ONC), setting interoperability standards now widely deployed in clinical settings in the U.S. Previously, Rich ran the IDX Flowcast Hospital business and prior to that was Vice President of Product Development for IDX Flowcast.
Rich served on ONC’s Health Information Technology Standards Federal Advisory Committee. He also co-chaired the ONC Interoperability Standards Advisory Task Force and the ONC Content Standards Workgroup. Rich currently serves on the Board of Directors of VITL, Vermont’s legislatively designated health information exchange. He also serves on the board of directors for several private health information technology and services companies. He has degrees from Dartmouth College (BA) and New School University (MA Economics).
Lisa Hammond serves as the Chief Human Resources Officer for Allscripts. Along with her team, she is accountable for setting the vision and strategy for supporting all Allscripts associates. Lisa has more than 25 years’ experience in Human Resources across various industries, including healthcare, hospitality and retail. Prior to joining Allscripts in 2020 to lead the Optimization, Talent Development and Talent Acquisition teams, Lisa worked with companies such as Pizza Hut Corporation, On the Border, ACG Texas LP, and Samsung Electronics America, and has additional experience in operations, marketing, and sales.
Leah is the Chief Financial Officer for Allscripts. Previously, she was responsible for the Ambulatory business unit, which included the development and client deployment of ambulatory-focused EHRs and financial systems, as well as Allscripts® Revenue Cycle Management Services and Allscripts population health assets for independent physicians. Leah has worked in the technology industry for more than 20 years, gaining experience in complex and creative negotiations, sales support systems and workflows, technical accounting and team leadership.
Prior to her current role, Leah led Global Sales Operations at Allscripts, a role in which she collaborated with clients, partners and internal teams to achieve successful relationships and respective performance goals. She is involved in various cross-functional leadership teams such as Pricing Committee and Allscripts Women’s Experience (AWE). She holds an advisory role on the board for Conversa Health, an Allscripts solution partner.
Before joining Allscripts, she held various leadership roles at Infor Global Solutions, Georgia-Pacific, MedQuist and Radiant Systems. Leah graduated with honors from Auburn University with a bachelor’s degree in Accounting and is a licensed CPA in the state of Georgia.
Tom Langan is the President and Chief Commercial Officer. Tom has served as a senior executive bringing extensive life sciences, payer and data & analytics experience. He has more than 25 years of broad-based functional experience in sales, marketing, strategy and P&L management.
Tom leads the Veradigm business unit within Allscripts. Veradigm is the brand for our Payer, Life Science, & Provider business unit.
Previously, Tom has held executive positions at Symphony Health Solutions and MediMedia where he managed their life sciences data, analytics and consulting business, market access and multi-channel marketing solutions. During his career, Tom has served as President, Chief Commercial Officer, SVP of Sales and various business development roles working with payers, employers and life sciences organizations.
Tom received a B.A. in Political Science from Fordham University in New York. He resides in Monmouth County, NJ, with his wife and children.
As senior vice president and general counsel, Tejal Vakharia leads the day-to-day legal and compliance affairs of the company, as well as the company’s government affairs group. As general counsel, Tejal advises the board of directors and executive management on all legal matters, including those relating to merger and acquisitions, contracts, partnerships, employment, litigation, regulatory affairs, cybersecurity, intellectual property and governance. She continues to lead the company’s global compliance department, which she established, and is responsible for areas such as privacy and security, healthcare compliance, the foreign corrupt practices act, pharmaceutical and medical device regulations, antitrust, health reform and reimbursement. Previously, Tejal served as senior vice president and chief compliance counsel for Allscripts. Prior to joining Allscripts, she held business, compliance and legal leadership positions at General Electric and Abbott Laboratories, and was an attorney at the multinational law firms of Foley & Lardner and Dentons.
Tejal serves on the Board of Directors of the United Way of Lake County and is the Chair of the Little Kids, Big Futures Fund, which has provided more than half of a million dollars in grants to nonprofits in Lake County, Illinois, to help fund early childhood education in underserved and vulnerable communities. In addition to being recognized for her problem-solving skills with multiple awards, she has received the Public Interest Law Initiative Distinguished Alumni Award and the Outstanding Corporate Counsel Award from the Chicago Bar Association.
Tejal earned Juris Doctor and Masters in Public Policy degrees from the University of Michigan, as well as Masters in Social Science and Bachelors in Philosophy from the University of Chicago.
Board of Directors
Beth Altman has more than 25 years of experience in accounting, finance, management, business development, strategic planning and corporate governance at accounting firm KPMG. Most recently and until her retirement on September 2019, Ms. Altman served as an Office Managing Partner, where she successfully led a team of more than 260 professionals and 23 partners, providing an array of assurance, tax and advisory services to public and private companies across all industry sectors. Additionally, Beth served as the lead audit partner for numerous early-stage, middle-market and large global clients in the public and private markets, predominantly in the life sciences, consumer markets and technology sectors. Since October 2019, Beth has served on the board of directors and on the audit committee of CV Sciences, Inc., which trades on the OTC:QB Marketplace. Beth also served as a board member of the Corporate Directors Forum, a 501(c)(6) nonprofit organization focused on helping directors, and those who support them, build more effective boards through continuous learning and peer networking. She also held a leadership position in the San Diego Chapter of Women Corporate Directors, the world’s largest membership organization and community of today’s preeminent women leaders in business.
Mara G. Aspinall is president and CEO of Health Catalysts, an investment and advisory firm dedicated to the growth of new healthcare companies. Aspinall is also executive chairman of GenePeeks, a computational genomics company, and is a member of the board of directors of Safeguard Scientifics, Abcam plc, Castle Biosciences and Blue Cross Blue Shield Arizona. Before joining Health Catalysts, Aspinall was president and CEO of Ventana Medical Systems division of Roche, a worldwide leader in development and commercialization of tissue-based cancer diagnostics. She previously spent 12 years as president of Genzyme Genetics and Genzyme Pharmaceuticals. In addition to running commercial enterprises, Aspinall co-founded the International School of Biomedical Diagnostics at Arizona State University, the first school dedicated entirely to Diagnostics as an independent discipline.
Paul Black currently serves as board member and chief executive officer (CEO) of Allscripts. As CEO, Paul guides company direction to fulfill its global commitment to build open, connected communities of health.
Before joining Allscripts in 2012, Paul spent more than 13 years with Cerner Corporation in various executive positions, retiring as Cerner’s chief operating officer in 2007. During his tenure with Cerner, he helped build the company into a market leader in healthcare information technology with more than $1.5 billion in annual revenue. Paul also spent 12 years with IBM Corporation in a variety of leadership positions in sales, product marketing and professional services.
Paul has served on several private company and nonprofit boards of directors for companies in healthcare information technology, healthcare services and consumer Internet marketing. He is currently immediate past chairman and an officer of Truman Medical Centers, a 400-bed safety net academic hospital in Kansas City, Missouri. Paul holds a Bachelor of Science degree from Iowa State University and a Master of Business Administration from the University of Iowa.
Gregory Garrison was a senior leader of PricewaterhouseCoopers for more than 20 years, most recently serving as its vice chairman and chief operating officer. He has experience in strategic planning, operations, finance, information technology, mergers and acquisitions, human capital, sales and marketing. Over the course of his career, he has spent considerable time meeting and working with various regulators, as well as advising numerous boards and audit committees. Among other qualifications, Greg brings experience as a successful business and operations leader, professional advisor and recognized financial expert.
Jonathan J. Judge currently serves on the board of directors of FEXCO Holdings Ltd., a global provider of finance and business solutions, headquartered in Ireland. From 2004 to early 2016, he served on the board of directors of PMC-Sierra, Inc., and held positions as chairman of the board and chairman of the compensation committee. From August 2010 until his retirement in January 2013, Jonathan served as the chief executive officer of First Data Corporation, a global leader in electronic commerce and payment processing. Prior to that, he served as the president and chief executive officer of Paychex Inc., a provider of payroll and human services. He also served as president and chief executive officer of Crystal Decisions, Inc. from 2002 until its merger with Business Objects S.A. in December 2003. Previously, he was employed by IBM Corporation, where he held senior management positions, most recently as general manager of its personal computing division. Among other qualifications, he brings 45 years of experience in the technology industry and extensive management, leadership and global operations expertise.
Michael A. Klayko has served as chairman of the board since March 2014. He currently serves as the chief executive officer of MKA Capital, an investment company focused on technology investments. Previously, he was chief executive officer of AOptix Technologies, Inc., a privately held provider of wireless communications and mobile network solutions, and chief executive officer of Brocade Communications Systems, Inc., a comprehensive network solutions provider. He has held executive positions, including CEO, at Rhapsody Networks, Inc., McDATA Corp., EMC Corporation, Hewlett-Packard Company and IBM Corporation. Within the past five years, Michael has served as a director of Bally Technologies, Inc., a publicly traded manufacturer of slot machines and other gaming technologies; PMC-Sierra, Inc., a publicly traded semiconductor company; and several other private companies in the technology industry. Among other qualifications, he brings more than 35 years of leadership experience in the technology industry, as well as extensive experience in the management of worldwide operations, sales and support.
Dave B. Stevens is the founder and managing director of Keelan Capital LLC, and serves as an advisor to a variety of venture capital and private equity firms and enterprises in the technology industry. He served for three years as a director of Imation Corp., a provider of global scalable storage and data security solutions. Dave was also the chief technology officer of Brocade Communications Systems, Inc., a provider of networking solutions for data centers, enterprises and service providers, having re-joined the company through its acquisition of Rhapsody Networks, for which he was the founding chief executive officer and vice president of business development. Previously, he was co-founder and chief executive officer of Palo Alto Networks, Inc., a leader in the development of cybersecurity and next-generation firewall products. He also served as the chief technology officer of transport systems for Brocade Communications Systems, Inc., and in senior management positions at Atmosphere Networks, Nortel, Bay Networks and SynOptics Communications. Among other qualifications, he brings extensive technology experience in the security, computer and data storage industries.
David D. Stevens currently serves as a private advisor and investor in private equity in the healthcare services industry. From 1983 to 2006, he held various executive roles at Accredo Health Group, Inc. (formerly known as Accredo Health 7, Inc.) and its predecessor companies, serving as its chief executive officer, chairman of the board, president and chief operating officer. David currently is a director of Wright Medical Group, Inc., a publicly traded orthopedic company that designs, manufactures and distributes extremity and biologic solutions, and several privately held healthcare companies. During the past five years, he has served as a director of Medco Health Solutions, Inc., a pharmacy benefits management company that was publicly traded before its acquisition by Express Scripts, Inc. in 2012; Thomas & Betts Corporation, a manufacturer of electrical, electronic, mechanical and utility products that was publicly traded before its acquisition by ABB Ltd in 2012; and Viasystems Group, Inc., a leading manufacturer of complex multilayer printed circuit boards and electro-mechanical solutions that was publicly traded before its acquisition by TTM Technologies, Inc. in 2015. Among other qualifications, he brings extensive financial and operating expertise, leadership experience, experience with serving on boards of directors and significant experience in the healthcare industry.
Carol Zierhoffer has more than 30 years of experience in information technology. Most recently and until her retirement in October 2019, Zierhoffer served as the Senior Vice President and Global Chief Information Officer at Bechtel Corporation, where she oversaw the company’s Global Information Systems & Technology organization. Zierhoffer’s responsibilities included Bechtel’s business and technology solutions, cybersecurity, infrastructure and operations, innovation, emerging technology and knowledge management for the company’s business lines and projects worldwide. Prior to her time at Bechtel, Zierhoffer served as Vice President and Global Chief Information Officer of Xerox Corporation from 2012 through 2013. She also served as Vice President and Global Chief Information Officer of ITT Corporation from 2008 through 2011 and Vice President and Chief Information Officer of three Northrop Grumman Corporation sectors – Electronics, Information Technology and Mission Systems – from 2002 through 2008. Zierhoffer was a member of the board of directors, as well as the chair of the information technology committee and on the audit committee, of MedAssets, Inc., from April 2013 through January 2016. Currently, Ms. Zierhoffer serves on the board of directors of Vizient Inc., on the executive advisory board of Nutanix, Inc. and as a founding board member of A Little Compassion, a non-profit company focused on creating opportunities for young adults with disabilities to build a bridge to adulthood.